Save on Wegovy Injection with Coupons, Discounts & Savings Programs

Wegovy Injection is the brand name for semaglutide and is available as a subcutaneous injection.

Wegovy Injection is available as a pre-filled, single-dose pen that delivers doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg.

Wegovy Injection is a GLP-1 agonist and is used for the following: Long-term treatment for weight management in: Adults with a body mass index (BMI) of 30 kg/m2 or greater; or BMI of 27 kg/m2 or greater and a weight-related condition (e.g., high blood pressure, Type 2 diabetes, high cholesterol) Children 12 years of age and older with a baseline BMI at the 95th percentile or greater Lowering the risk of heart attack, stroke, and death due to heart problems in adults with heart disease and a larger body size

Wegovy Injection is a glucagon-like peptide-1 (GLP-1) agonist. It works similarly to GLP-1, a hormone that your body normally makes that regulates your appetite. Wegovy Injection slows down your gut, helps you feel fuller after you eat, and controls your appetite.

Wegovy Injection is typically started at 0.25 mg injected under your skin once a week for 4 weeks (1 month). Your primary care provider will raise your dose every 4 weeks until you reach the maintenance dose. The standard dosing schedule for Wegovy Injection might look like: 

• Month 1: Inject 0.25 mg once a week
• Month 2: Inject 0.5 mg once a week
• Month 3: Inject 1 mg once a week
• Month 4: Inject 1.7 mg once a week
• Month 5 and beyond (maintenance dose): Inject 2.4 mg once a week. Adults also have the option to inject 1.7 mg once a week as the maintenance dose

Wegovy Injection is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication if any of the following apply. Personal or family history of MTC or in patients with MEN2. Known hypersensitivity to semaglutide or any of the excipients in Wegovy Injection.

Common side effects of Wegovy Injection: 

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Stomach pain
• Headache
• Tiredness

Serious side effects are rare with Wegovy Injection. Contact your healthcare provider immediately if you experience any of the following. 

• Gallbladder or pancreas problems: pain, swelling, or tenderness in the stomach; fever; yellowing of the skin or eyes
• Serious allergic reaction: facial swelling, closing of the throat, trouble breathing, hives
• Thoughts of self-harm

The following medications may interact with Wegovy Injection: 

• Wegovy Injection delays gastric emptying. May impact absorption of concomitantly administered oral medications. Use with caution

Novo Nordisk Inc.

Wegovy Injection may harm your unborn baby. You should stop using Wegovy Injection 2 months before you plan to become pregnant. There is a pregnancy exposure registry for women who use Wegovy Injection during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry or you may contact Novo Nordisk at 1-877-390-2760.

• Semaglutide